Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marinchak

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
The American Journal of Cardiology|November 11, 1998
Atrial fibrillation trials: will they teach us what we need to know?P R Kowey, R A Marinchak, S J Rials, et al.
Pacing and Clinical Electrophysiology : PACE|January 1, 1988
Effect of antiarrhythmic drugs on defibrillation threshold: case report of an adverse effect of mexiletine and review of the literatureR A Marinchak, T D Friehling, R A Kline, et al.
The American Journal of Cardiology|June 1, 1990
Effectiveness of propranolol added to a type I antiarrhythmic agent for sustained ventricular tachycardia secondary to coronary artery diseaseT D Friehling, H Lipshutz, R A Marinchak, et al.
American Heart Journal|April 1, 1991
Propafenone for malignant ventricular arrhythmia: an analysis of the literatureM Hernandez, R F Reder, R A Marinchak, et al.
Circulation|June 13, 2001
Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome : direct evidence from intracellular recordings in the intact left ventricular wallG X Yan, Y Wu, T Liu, et al.
American Heart Journal|November 1, 1993
Evidence for a reexcitability gap in man after treatment with type I antiarrhythmic drugsR J Haberman, S J Rials, J L Stohler, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Effects of captopril treatment of renovascular hypertension on beta-adrenergic modulation of L-type Ca(2+) currentX Xu, S J Rials, Y Wu, et al.
Chest|January 1, 1988
Safety and efficacy of amiodarone. The low-dose perspectiveP R Kowey, T D Friehling, R A Marinchak, et al.
Circulation|August 19, 1997
Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillationS J Rials, Y Wu, X Xu, et al.
American Heart Journal|November 1, 1996
Effect of an intravenous angiotensin-converting enzyme inhibitor on the electrophysiologic features of normal and hypertrophied feline ventriclesS J Rials, Y Wu, F J Pauletto, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
The American Journal of Cardiology|November 11, 1998
Atrial fibrillation trials: will they teach us what we need to know?P R Kowey, R A Marinchak, S J Rials, et al.
Pacing and Clinical Electrophysiology : PACE|January 1, 1988
Effect of antiarrhythmic drugs on defibrillation threshold: case report of an adverse effect of mexiletine and review of the literatureR A Marinchak, T D Friehling, R A Kline, et al.
The American Journal of Cardiology|June 1, 1990
Effectiveness of propranolol added to a type I antiarrhythmic agent for sustained ventricular tachycardia secondary to coronary artery diseaseT D Friehling, H Lipshutz, R A Marinchak, et al.
American Heart Journal|April 1, 1991
Propafenone for malignant ventricular arrhythmia: an analysis of the literatureM Hernandez, R F Reder, R A Marinchak, et al.
Circulation|June 13, 2001
Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome : direct evidence from intracellular recordings in the intact left ventricular wallG X Yan, Y Wu, T Liu, et al.
American Heart Journal|November 1, 1993
Evidence for a reexcitability gap in man after treatment with type I antiarrhythmic drugsR J Haberman, S J Rials, J L Stohler, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Effects of captopril treatment of renovascular hypertension on beta-adrenergic modulation of L-type Ca(2+) currentX Xu, S J Rials, Y Wu, et al.
Chest|January 1, 1988
Safety and efficacy of amiodarone. The low-dose perspectiveP R Kowey, T D Friehling, R A Marinchak, et al.
Circulation|August 19, 1997
Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillationS J Rials, Y Wu, X Xu, et al.
American Heart Journal|November 1, 1996
Effect of an intravenous angiotensin-converting enzyme inhibitor on the electrophysiologic features of normal and hypertrophied feline ventriclesS J Rials, Y Wu, F J Pauletto, et al.
Pageof 7